Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Sorrento Therapeutics Inc.
Headquarters: San Diego, CA, United States of America
Website: http://www.sorrentotherapeu...
Year Founded: 2006
Status: Public
Industry Sector: HealthTechnology
CEO: Henry H. Ji, PhD
Number Of Employees: N/A
Enterprise Value: N/A
PE Ratio: 0
Exchange/Ticker 1: Pink:SRNEQ
Exchange/Ticker 2: N/A
Latest Market Cap: $551,300
BioCentury | Apr 13, 2023
Management Tracks
SVB’s Sabow to lead HSBC tech, healthcare business
Plus: Century revamps C-suite amid CEO departure and updates from Bausch + Lomb, Gennao, Celares, Sherlock, Viridian and more
BioCentury | Mar 24, 2023
Finance
Who’s gone? A snapshot of biotechs closing doors
Biotech struck by a wave of downsizing, restructuring and closures, as companies run out of options in an unforgiving market
BioCentury | Jan 19, 2023
Data Byte
Intranasal COVID-19 interventions in clinical trials
The clinical pipeline of inhaled vaccines and therapies remains slim, early stage
BioCentury | Jun 28, 2022
Management Tracks
Moore becomes CSO at Zymeworks
Plus new COO and CBO at Cellino, and updates from Aclaris, Amryt, TCR2 and more
BioCentury | Apr 28, 2022
Management Tracks
Marioni to lead computational effort at Genentech’s gRED
Plus new COO, CMO at I-Mab, updates from TwinStrand, Chimera, CyTek and more
BioCentury | Mar 19, 2022
Deals
March 18 Quick Takes: Amylyx launches expanded access for ALS therapy
Plus Moderna requests EUA of second booster dose, updates from Apexigen, Scilex, Revel and more
BioCentury | Jan 11, 2022
Management Tracks
Suliman named CEO of ReCode
Plus Cohen leaving Adaptive as CFO and updates from iTeos, Sorrento and more
BioCentury | Dec 7, 2021
Management Tracks
Biohaven names Coric chair, Buten CFO
Plus: Mutamba joins Arrakis as CBO and updates from Goldfinch, Kymera, AnHeart and more
BioCentury | Nov 16, 2021
Data Byte
The oncolytic virus pipeline
At least 49 oncolytic virus therapies now in development behind the sole FDA-approved product
BioCentury | Oct 5, 2021
Product Development
Lengthy TRPV1 pipeline now backed by Nobel prize
The now Nobel Prize-winning discovery of TRPV1 has led to a well-stocked therapeutic pipeline
Items per page:
1 - 10 of 163